Strengths
Lunit's innovative AI technology enhances cancer detection and treatment, providing a significant advantage in the healthcare sector.
The company has a strong global presence, with partnerships across 50+ countries, which enhances its credibility and reach.
Lunit's technology is backed by extensive research, with over 200 studies supporting its effectiveness and reliability.
The brand has been recognized in prestigious challenges, such as ranking first in the CAMELYON Grand Challenge 2017, showcasing its leading technology.
Lunit's AI can predict breast cancer risk up to 6 years in advance, providing a significant advantage in early detection.